However, based on the Rembrandt database (http://www.betastasis.com/glioma/rembrandt/) (26), the survival time of GBM patients with higher expression of GSDME was significantly shorter than that of patients with lower expression (P = 0.022; Supplementary Figure 3B). This evidence concerns the gene GSDME and central nervous system cancer.